The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Chutko L.S.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Surushkina S.Yu.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Yakovenko E.A.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Cherednichenko D.V.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Attention deficit hyperactivity disorder in adults

Authors:

Chutko L.S., Surushkina S.Yu., Yakovenko E.A., Cherednichenko D.V.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(2): 97‑102

DOI: 10.17116/jnevro202412402197

Read: 4034 times

Download PDF (RU)
Contact the author
Table of contents

ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS
ATTENTION DEFICIT HYPERACTIVITY DISORDER IN ADULTS

To cite this article:

Chutko LS, Surushkina SYu, Yakovenko EA, Cherednichenko DV. Attention deficit hyperactivity disorder in adults. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(2):97‑102. (In Russ.)
https://doi.org/10.17116/jnevro202412402197

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Atte­ntion defi­cit hype­ractivity diso­rder in adolescents. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(9):42-49
Atte­ntion defi­cit hype­ractivity diso­rder: pharmacotherapy in special situations. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(10):59-65
Classification, diagnosis and therapy of atte­ntion defi­cit hype­ractivity diso­rder. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(11):62-68
Abstract:

The article presents a review of scientific publications devoted to the study of the characteristics of the clinical picture and the dynamics of the main symptoms in adult patients with attention deficit hyperactivity disorder (ADHD). The authors present current data on the prevalence of this disease, leading clinical manifestations and the most common comorbid pathology. Research data on the impact of ADHD in adulthood on educational and professional activities are presented, and the economic and criminological aspects of ADHD are considered. The main methods of psychotherapeutic correction and pharmacological therapy are presented.

Keywords:

attention deficit hyperactivity disorder in adults
atomoxetine
kognittera

Authors:

Chutko L.S.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Surushkina S.Yu.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Yakovenko E.A.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Cherednichenko D.V.

N. Bekhtereva Institute of Human Brain Russian Academy of Sciences

Received:

16.01.2024

Accepted:

26.01.2024

Close metadata

References:

  1. Salari N, Ghasemi H, Abdoli N, et al. The global prevalence of ADHD in children and adolescents: a systematic review and meta-analysis. Ital J Pediatr. 2023;49(1):48.  https://doi.org/10.1186/s13052-023-01456-1
  2. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56:14-34.  https://doi.org/10.1016/j.eurpsy.2018.11.001
  3. Dobrosavljevic M, Solares C, Cortese S, et al. Prevalence of attention-deficit/hyperactivity disorder in older adults: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2020;118:282-289.  https://doi.org/10.1016/j.neubiorev.2020.07.042
  4. Song P, Zha M, Yang Q, et al. The prevalence of adult attention-deficit hyperactivity disorder: A global systematic review and meta-analysis. J Glob Health. 2021;11:04009. https://doi.org/10.7189/jogh.11.04009
  5. Vos M, Hartman CA. The decreasing prevalence of ADHD across the adult lifespan confirmed. J Glob Health. 2022;12:03024. https://doi.org/10.7189/jogh.12.03024
  6. Skogli EW, Teicher MH, Andersen PN, et al. ADHD in girls and boys—Gender differences in co-existing symptoms and executive function measures. BMC Psychiatry. 2013;13:298.  https://doi.org/10.1186/1471-244X-13-298
  7. Sayal K, Prasad V, Daley D, et al. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry. 2018;5(2):175-186.  https://doi.org/10.1016/S2215-0366(17)30167-0
  8. Williamson D, Johnston C. Gender differences in adults with attention-deficit/hyperactivity disorder: A narrative review. Clin Psychol Rev. 2015;40:15-27.  https://doi.org/10.1016/j.cpr.2015.05.005
  9. Faheem M, Akram W, Akram H, et al. Gender-based differences in prevalence and effects of ADHD in adults: A systematic review. Asian J Psychiatr. 2022;75:103205. https://doi.org/10.1016/j.ajp.2022.103205
  10. Luck SJ, Hahn B, Leonard CJ, Gold JM. The hyperfocusing hypothesis: A new account of cognitive dysfunction in schizophrenia. Schizophrenia Bulletin. 2019;45(5):991-1000. https://doi.org/10.1093/schbul/sbz063
  11. Ozel-Kizil E, Demirbas H, Bastug G, et al. P.7.b.012 A scale for the assessment of hyperfocusing in attention deficit and hyperactivity disorder. European Neuropsychopharmacology. 2013;23(2):S593. https://doi.org/10.1016/S0924-977X(13)70944-1
  12. Hupfeld KE, Abagis TR, Shah P. Living «in the zone»: Hyperfocus in adult ADHD. ADHD Attention Deficit and Hyperactivity Disorders. 2019;11(2):191-208.  https://doi.org/10.1007/s12402-018-0272-y
  13. Hirsch O, Chavanon M, Riechmann E, Christiansen H. Emotional dysregulation is a primary symptom in adult Attention-Deficit/Hyperactivity Disorder (ADHD). J Affect Disord. 2018;232:41-47.  https://doi.org/10.1016/j.jad.2018.02.007
  14. Mancini C, Van Ameringen M, Oakman JM, Figueiredo D. Childhood attention deficit/hyperactivity disorder in adults with anxiety disorders. Psychol Med. 1999;29(3):515-525.  https://doi.org/10.1017/s0033291798007697
  15. Chutko LS, Surushkina SYu, Iakovenko EA, et al. Attention deficit syndrome in adults: clinical, psychophysiological features and treatment. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2013;113(8):38-41. (In Russ.).
  16. Chutko LS, Surushkina SYu, Iakovenko EA, et al. Diagnosis and treatment of cognitive impairment in adults with attention deficit hyperactivity disorder. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2017;117(5):9-13. (In Russ.). https://doi.org/10.17116/jnevro2017117519-13
  17. Chutko LS, Surushkina SYu, Iakovenko EA, et al. Cognitive control impairment in adult with attention deficit/hyperactivity disorder. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2018;118(12):31-35. (In Russ.). https://doi.org/10.17116/jnevro201811812131
  18. Shapero BG, Gibb BE, Archibald A, et al. Risk Factors for Depression in Adolescents With ADHD: The Impact of Cognitive Biases and Stress. J Atten Disord. 2021;25(3):340-354.  https://doi.org/10.1177/1087054718797447
  19. Stickley A, Koyanagi A. Physical multimorbidity and loneliness: A population-based study. PLoS One. 2018;13(1):e0191651. https://doi.org/10.1371/journal.pone.0191651
  20. Fitzgerald C, Dalsgaard S, Nordentoft M, Erlangsen A. Suicidal behaviour among persons with attention-deficit hyperactivity disorder. Br J Psychiatry. 2019;7:1-6.  https://doi.org/10.1192/bjp.2019.128
  21. Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: Results from the National Comorbidity Survey Replication. Am J Psychiatry. 2006;163:716-723.  https://doi.org/10.1176/ajp.2006.163.4.716
  22. Van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, et al. Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: A meta-analysis and meta-regression analysis. Drug Alcohol Depend. 2012;122(1-2):11-19.  https://doi.org/10.1016/j.drugalcdep.2011.12.007
  23. Zulauf CA, Sprich SE, Safren SA, Wilens TE. The complicated relationship between attention deficit/hyperactivity disorder and substance use disorders. Curr Psychiatry Rep. 2014;16(3):436.  https://doi.org/10.1007/s11920-013-0436-6
  24. Anker E, Haavik J, Heir T. Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: Prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation. World J Psychiatry. 2020;10(9):202-211.  https://doi.org/10.5498/wjp.v10.i9.202
  25. Rasmussen P, Gillberg C. Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. J Am Acad Child Adolesc Psychiatry. 2000;39(11):1424-1431. https://doi.org/10.1097/00004583-200011000-00017
  26. Green AL, Rabiner DL. What do we really know about ADHD in college students? Neurotherapeutics. 2012;9(3):559-568.  https://doi.org/10.1007/s13311-012-0127-8
  27. Prevatt F, Young JL. Recognizing and treating attention-deficit/hyperactivity disorder in college students. Journal of College Student Psychotherapy. 2014;28(3):182-200.  https://doi.org/10.1080/87568225.2014.914825
  28. Lewandowski LJ, Lovett BJ, Codding RS, Gordon M. Symptoms of ADHD and academic concerns in college students with and without ADHD diagnoses. J Atten Disord. 2008;12(2):156-161.  https://doi.org/10.1177/1087054707310882
  29. Adamou M, Arif M, Asherson P, et al. Occupational issues of adults with ADHD. BMC Psychiatry. 2013;13:59.  https://doi.org/10.1186/1471-244X-13-59
  30. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256.  https://doi.org/10.1017/s0033291704002892
  31. Bangma DF, Tucha L, Fuermaier ABM, et al. Financial decision-making in a community sample of adults with and without current symptoms of ADHD. PLoS One. 2020;15(10):e0239343. https://doi.org/10.1371/journal.pone.0239343
  32. Daley D, Jacobsen RH, Lange AM, et al. The economic burden of adult attention deficit hyperactivity disorder: A sibling comparison cost analysis. Eur Psychiatry. 2019;61:41-48.  https://doi.org/10.1016/j.eurpsy.2019.06.011
  33. Ahlberg R, Du Rietz E, Ahnemark E, et al. Real-life instability in ADHD from young to middle adulthood: a nationwide register-based study of social and occupational problems. BMC Psychiatry. 2023;23(1):336.  https://doi.org/10.1186/s12888-023-04713-z
  34. Montano B. Diagnosis and treatment of ADHD in adults in primary care. J Clin Psychiatry. 2004;65(suppl 3):18-21. 
  35. Barkley RA. Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood. Postgrad Med. 2008;120(3):48-59.  https://doi.org/10.3810/pgm.2008.09.1907
  36. Altszuler AR, Page TF, Gnagy EM, et al. Financial Dependence of Young Adults with Childhood ADHD. J Abnorm Child Psychol. 2016;44(6):1217-1229. https://doi.org/10.1007/s10802-015-0093-9
  37. Beauchaine TP, Ben-David I, Bos M. ADHD, financial distress, and suicide in adulthood: A population study. Sci Adv. 2020;6(40):eaba1551. https://doi.org/10.1126/sciadv.aba1551
  38. Ginsberg Y, Hirvikoski T, Lindefors N. Attention Deficit Hyperactivity Disorder (ADHD) among longer-term prison inmates is a prevalent, persistent and disabling disorder. BMC Psychiatry. 2010;10:112.  https://doi.org/10.1186/1471-244X-10-112
  39. Freckelton I. Attention Deficit Hyperactivity Disorder (ADHD) and the Criminal Law. Psychiatry, Psychology, and Law. 2020;26:817-840.  https://doi.org/10.1080/13218719.2019.1695266
  40. Erskine HE, Norman RE, Ferrari AJ, et al. Long-Term Outcomes of Attention-Deficit/Hyperactivity Disorder and Conduct Disorder: A Systematic Review and Meta-Analysis. J Am Acad Child Adolesc Psychiatry. 2016;55(10):841-850.  https://doi.org/10.1016/j.jaac.2016.06.016
  41. Knecht C, de Alvaro R, Martinez-Raga J, Balanza-Martinez V. Attention-deficit hyperactivity disorder (ADHD), substance use disorders, and criminality: a difficult problem with complex solutions. Int J Adolesc Med Health. 2015;27(2):163-175.  https://doi.org/10.1515/ijamh-2015-5007
  42. Young S, Cocallis K. Attention Deficit Hyperactivity Disorder (ADHD) in the Prison System. Current Psychiatry Reports. 2019;21:41.  https://doi.org/10.1007/s11920-019-1022-3
  43. Cahill BS, Coolidge FL, Segal DL, et al. Prevalence of ADHD and its subtypes in male and female adult prison inmates. Behav Sci Law. 2012;30(2):154-166.  https://doi.org/10.1002/bsl.2004
  44. Rösler M, Retz W, Retz-Junginger P, et al. Prevalence of attention-deficit hyperactivity disorder in male young adult prison inmates. Eur Arch Psychiatry Clin Neurosci. 2004;254(6):365-371.  https://doi.org/10.1007/s00406-004-0516-z
  45. Gudjonsson GH, Sigurdsson JF, Sigfusdottir ID, et al. A national epidemiological study investigating risk factors for police interrogation and false confession among juveniles and young persons. Soc Psychiatry Psychiatr Epidemiol. 2016;51(3):359-567.  https://doi.org/10.1007/s00127-015-1145-8
  46. Fuermaier AB, Tucha L, Evans BL, et al. Driving and attention deficit hyperactivity disorder. J Neural Transm (Vienna). 2017;124(suppl 1):55-67.  https://doi.org/10.1007/s00702-015-1465-6
  47. Fuermaier ABM, Tucha L, Koerts J, et al. Cognitive impairment in adult ADHD-perspective matters! Neuropsychology. 2015;29(1):45-58.  https://doi.org/10.1037/neu0000108
  48. Kingery KM, Narad M, Garner AA, et al. Extended Visual Glances Away from the Roadway are Associated with ADHD- and Texting-Related Driving Performance Deficits in Adolescents. J Abnorm Child Psychol. 2015;43(6):1175-1186. https://doi.org/10.1007/s10802-014-9954-x
  49. Chang Z, Lichtenstein P, D’Onofrio BM, et al. Serious transport accidents in adults with attention-deficit/hyperactivity disorder and the effect of medication: a population-based study. JAMA Psychiatry. 2014;71(3):319-325.  https://doi.org/10.1001/jamapsychiatry.2013.4174
  50. Groom MJ, van Loon E, Daley D, et al. Driving behaviour in adults with attention deficit/hyperactivity disorder. BMC Psychiatry. 2015;15:175.  https://doi.org/10.1186/s12888-015-0566-y
  51. Shin IH, Lee DS, Chen CL. The role of trait impulsivity in response inhibition: event-related potentials in a stop-signal task. Int J Psychophysiol. 2014;91(2):80-87.  https://doi.org/10.1016/j.ijpsycho.2013.11.004
  52. Bron TI, Bijlenga D, Breuk M, et al. Risk factors for adverse driving outcomes in Dutch adults with ADHD and controls. Accid Anal Prev. 2018;111:338-344.  https://doi.org/10.1016/j.aap.2017.12.011
  53. Hirvikoski T, Lindstrom T, Carlsson J, et al. Psychoeducational groups for adults with ADHD and their significant others (PEGASUS): A pragmatic multicenter and randomized controlled trial. European psychiatry. 2017;44:141-152.  https://doi.org/10.1016/j.eurpsy.2017.04.005
  54. Knouse LE, Safren SA. Current status of cognitive behavioral therapy for adult attention-deficit hyperactivity disorder. Psychiatr Clin North Am. 2010;33(3):497-509.  https://doi.org/10.1016/j.psc.2010.04.001
  55. Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms a randomized controlled trial. JAMA. 2010;304:875-880.  https://doi.org/10.1001/jama.2010.1192
  56. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818.  https://doi.org/10.1016/j.neubiorev.2021.01.022
  57. Simpson D, Plosker GL. Atomoxetine: a review of its use in adults with attention deficit hyperactivity disorder. Drugs. 2004;64(2):205-222.  https://doi.org/10.2165/00003495-200464020-00005
  58. Scott NG, Ripperger-Suhler J, Rajab MH, Kjar D. Factors associated with atomoxetine efficacy for treatment of attention-deficit/hyperactivity disorder in children and adolescents. J Child Adolesc Psychopharmacol. 2010;20(3):197-203.  https://doi.org/10.1089/cap.2009.0104
  59. Nagai T, Kurihara T, Koya H, et al. Identification of factors associated with the efficacy of atomoxetine in adult attention-deficit/hyperactivity disorder. Neuropsychopharmacol Rep. 2022;42(3):249-255.  https://doi.org/10.1002/npr2.12253
  60. Savill N, Buitelaar J, Anand E, et al. The efficacy of atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A comprehensive review of over a decade of clinical research. CNS Drugs. 2015;29:131-151.  https://doi.org/10.1007/s40263-014-0224-9
  61. Clemow DB, Bushe C, Mancini M, et al. A review of the efficacy of atomoxetine in the treatment of attention-deficit hyperactivity disorder in children and adult patients with common comorbidities. Neuropsychiatr Dis Treat. 2017;13:357-371.  https://doi.org/10.2147/NDT.S115707
  62. Adler L, Liebowitz M, Kronenberger W, et al. Atomexetine treatment in adults with attention-deficit/hyperactivity disorder and comorbid social anxiety disorder. Depress Anxiety. 2009;26:212-221.  https://doi.org/10.1002/da.20549
  63. Gabriel A, Violato C. Adjunctive atomoxetine to SSRIs or SNRIs in the treatment of adult ADHD patients with comorbid partially responsive generalized anxiety (GA): an open-label study. Atten Defic Hyperact Disord. 2011;3(4):319-326.  https://doi.org/10.1007/s12402-011-0063-1
  64. Lenzi F, Cortese S, Harris J, Masi G. Pharmacotherapy of emotional dysregulation in adults with ADHD: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 2018;84:359-367.  https://doi.org/10.1016/j.neubiorev.2017.08.010
  65. Wilens TE, Adler LA, Tanaka Y, et al. Correlates of alcohol use in adults with ADHD and comorbid alcohol use disorders: exploratory analysis of a placebo-controlled trial of atomoxetine. Curr Med Res Opin. 2011;27(12):2309-2320. https://doi.org/10.1185/03007995.2011.628648
  66. Bangs ME, Wietecha LA, Wang S, et al. Meta-analysis of suicide-related behavior or ideation in child, adolescent, and adult patients treated with atomoxetine. J Child Adolesc Psychopharmacol. 2014;24(8):426-434.  https://doi.org/10.1089/cap.2014.0005
  67. Sobański JA, Dudek D. Psychiatry and neurology: from dualism to integration. Neurol Neurochir Pol. 2013;47(6):577-583.  https://doi.org/10.5114/ninp.2013.39069
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.